[Factors to consider in managing drug interactions in clinical practice].
The huge number of drug interactions makes it impossible to memorize them all. Detecting them and preventing adverse effects requires the use of reference works or databases. There are numerous discordances between the so-called "reference" books and databases. Nonexistent and unconfirmed interactions are published. The wording of the "drug interactions" section of the summary of product characteristics (SCP) sometimes sheds very little light on the risks involved. The delay by AFSSAPS in updating its drug interaction thesaurus may present problems in clinical practice. It is essential to know the limitations of the computerized systems for detecting and reporting drug interactions.
Service pharmacie, Hôpital de la Croix-Rousse, Hospices civils de Lyon, F-69317 Lyon Cedex 04, France. bruno.charpiat@chu-lyon.fr
Bruno
B
Charpiat
Benoit
B
Allenet
Renaud
R
Roubille
Laurence
L
Escofier
Pierrick
P
Bedouch
Michel
M
Juste
François-Xavier
FX
Rose
Ornella
O
Conort
D016907:Adverse Drug Reaction Reporting Systems; D016303:Clinical Pharmacy Information Systems; D004347:Drug Interactions; D006801:Humans; D010602:Pharmacopoeias as Topic; D012014:Reference Books, Medical